FANCG and breast cancer: The FANCG frameshift variant, c.637_643del p.(Tyr213LysfsTer6), detected in two breast cancer patients (BRB98 & BRB225), is a founder variant that is present in 82% of Fanconi anaemia subtype G patients from sub-Saharan African populations50.